Neil R Aggarwal
Overview
Explore the profile of Neil R Aggarwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DeMasi S, Imhoff B, Lewis A, Seitz K, Driver B, Gibbs K, et al.
medRxiv
. 2025 Jan;
PMID: 39867415
Background: Emergency tracheal intubation is a common and high-risk procedure. Ketamine and etomidate are sedative medicines commonly used to induce anesthesia for emergency tracheal intubation, but whether the induction medication...
2.
Paules C, Nordwall J, Shaw-Saliba K, Aberg J, Gardner E, Goodman A, et al.
BMC Infect Dis
. 2025 Jan;
25(1):67.
PMID: 39810077
Background: Low blood absolute lymphocyte count (ALC) may predict severe COVID-19 outcomes. Knowledge gaps remain regarding the relationship of ALC trajectory with clinical outcomes and factors associated with lymphopenia. Methods:...
3.
Balk R, Esper A, Martin G, Miller 3rd R, Lopansri B, Burke J, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39457994
SeptiCyte RAPID is a transcriptional host response assay that discriminates between sepsis and non-infectious systemic inflammation (SIRS) with a one-hour turnaround time. The overall performance of this test in a...
4.
Xiao M, Molina K, Aggarwal N, Beaty L, Bennett T, Carlson N, et al.
JAMA Health Forum
. 2024 Sep;
5(9):e242884.
PMID: 39269694
Importance: During the COVID-19 pandemic, the effective distribution of limited treatments became a crucial policy goal. Yet, limited research exists using electronic health record data and machine learning techniques, such...
5.
Molina K, Webb B, Kennerley V, Beaty L, Bennett T, Carlson N, et al.
BMC Infect Dis
. 2024 Aug;
24(1):802.
PMID: 39118052
Background: A trial performed among unvaccinated, high-risk outpatients with COVID-19 during the delta period showed remdesivir reduced hospitalization. We used our real-world data platform to determine the effectiveness of remdesivir...
6.
Gibbs K, Semler M, Driver B, Seitz K, Stempek S, Taylor C, et al.
N Engl J Med
. 2024 Jun;
390(23):2165-2177.
PMID: 38869091
Background: Among critically ill adults undergoing tracheal intubation, hypoxemia increases the risk of cardiac arrest and death. The effect of preoxygenation with noninvasive ventilation, as compared with preoxygenation with an...
7.
Ware L, Files D, Fowler A, Aboodi M, Aggarwal N, Brower R, et al.
JAMA
. 2024 May;
332(5):390-400.
PMID: 38762798
Importance: Acetaminophen (paracetamol) has many pharmacological effects that might be beneficial in sepsis, including inhibition of cell-free hemoglobin-induced oxidation of lipids and other substrates. Objective: To determine whether acetaminophen increases...
8.
Balk R, Esper A, Martin G, Miller 3rd R, Lopansri B, Burke J, et al.
J Clin Med
. 2024 Apr;
13(5).
PMID: 38592057
(1) SeptiCyte RAPID is a molecular test for discriminating sepsis from non-infectious systemic inflammation, and for estimating sepsis probabilities. The objective of this study was the clinical validation of SeptiCyte...
9.
Roberts S, Jolley S, Beaty L, Aggarwal N, Bennett T, Carlson N, et al.
J Med Virol
. 2024 Mar;
96(3):e29541.
PMID: 38516779
Effective therapies for reducing post-acute sequelae of COVID-19 (PASC) symptoms are lacking. Evaluate the association between monoclonal antibody (mAb) treatment or COVID-19 vaccination with symptom recovery in COVID-19 participants. The...
10.
Aggarwal N, Beaty L, Bennett T, Fish L, Jacobs J, Mayer D, et al.
Lancet Reg Health Am
. 2024 Mar;
31:100693.
PMID: 38500962
Background: Ritonavir-boosted Nirmatrelvir (NMV-r), a protease inhibitor with activity against SARS-CoV-2, can reduce risk of progression to severe COVID-19 among high-risk individuals infected with earlier variants, but less is known...